Skip to content

Escalation of intravenous self-administration of methylone and mephedrone under extended access conditions.

Jacques D. Nguyen, Yanabel Grant, Kevin M Creehan, Sophia A. Vandewater, Michael A. Taffe

Addiction Biology September 2017 DOI: 10.1111/adb.12398 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Population Male Wistar rats
Interventions Methylone Mephedrone Methamphetamine
Dose 0.5 mg/kg/infusion for self-administration training; progressive-ratio dose-substitution ranges: methylone 0.125-2.5 mg/kg/infusion, mephedrone 0.125-2.5 mg/kg/infusion, methamphetamine 0.01-0.5 mg/kg/infusion
Duration Short-access (2 h) and long-access (6 h) daily self-administration sessions
Topics MDMA
Keywords Bath salts Drug addiction Reward Substance abuse
Key findings Long-access (6-hour) self-administration of mephedrone escalated intake and produced significantly higher progressive-ratio breakpoints for mephedrone and methamphetamine than short-access or methylone-trained groups, whereas long-access methylone self-administration showed only a rightward shift in peak effective dose without an overall efficacy change. The authors conclude mephedrone carries greater risk for dysregulated drug consumption.

Abstract

The recreational use of substituted cathinones continues to grow as a public health concern in the United States. Studies have shown that extended access to intravenous (i.v.) self-administration of stimulants, such as cocaine and methamphetamine, results in escalation of drug intake relative to shorter access; however, little is known about the impact of extended access on self-administration of entactogen class stimulants such as methylone and 4-methylmethcathinone (mephedrone). Male Wistar rats were randomly assigned to short-access (ShA, 2- h) and long-access (LgA, 6- h) groups and trained to self-administer methylone or mephedrone (0.5 mg/kg/infusion) using a fixed-ratio 1 response contingency. The methylone-trained groups were evaluated on a progressive-ratio (PR) procedure incorporating dose-substitution of methylone (0.125-2.5 mg/kg/infusion), mephedrone (0.125-2.5 mg/kg/infusion) or methamphetamine (MA; 0.01-0.5 mg/kg/infusion). Mephedrone-trained rats were similarly evaluated on a PR with mephedrone and MA. Rats trained with LgA to methylone and mephedrone earned more infusions during acquisition compared with ShA groups. Mephedrone-trained LgA rats reached significantly higher breakpoints than all other groups in mephedrone and MA PR tests. Methylone-trained LgA rats exhibited a rightward shift of the peak effective dose but no overall efficacy change compared with methylone-trained ShA rats. These findings show that the self-administration of mephedrone escalates under LgA conditions in a manner similar to traditional stimulants whereas escalation of 6 h intakes of methylone is not accompanied by differences in PR performance. Thus mephedrone represents the greater risk for dysregulated drug consumption.

Comparable studies

Other preclinical and animal studies on MDMA, most cited first.

Citations in the library

Cited by 9

and 4 more in the library

Cites 8

and 3 more in the library

Explore topics